1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Vaccinex, Inc.

Vaccinex, Inc.

VCNX
Vaccinex, Inc.US flagOther OTC
1.18
USD
+0.31
- -
3.16MMarket Cap

Income Statement (USD)

APIChatGPT
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Sales/Revenue/Turnover
- -
- -
1
1
- -
1
- -
1
1
+ Sales & Services Revenue
- -
- -
1
1
- -
1
- -
1
1
- Cost of Revenue
- -
- -
1
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
1
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
1
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
-1
-1
- Operating Expenses
20
21
27
32
28
23
20
23
19
+ Selling, General & Admin
4
4
5
7
7
6
6
7
7
+ Research & Development
16
17
22
26
22
17
14
17
13
+ Other Operating Expense
- -
- -
- -
- -
-1
- -
- -
- -
- -
Operating Income (Loss)
-20
-21
-27
-32
-28
-22
-20
-23
-19
- Non-Operating (Income) Loss
-6
-2
2
- -
1
- -
- -
-3
- -
+ Interest Expense, Net
3
1
- -
- -
- -
1
- -
- -
- -
+ Interest Expense
3
1
- -
- -
- -
1
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
-9
-4
2
- -
- -
-1
- -
-3
- -
Pretax Income
-14
-19
-30
-32
-29
-22
-20
-20
-19
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-14
-19
-30
-32
-29
-22
-20
-20
-19
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-14
-19
-30
-32
-29
-22
-20
-20
-19
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-14
-19
-30
-32
-29
-22
-20
-20
-19
- Preferred Dividends
12
3
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-26
-22
-30
-32
-29
-22
-20
-20
-19
EBIT
-20
-21
-27
-32
-28
-22
-20
-23
-19
EBITDA
-20
-21
-27
-32
-28
-22
-20
-23
-19
EBITDA Margin (%)
-6,354.75
-23,220
-3,737.29
-6,073.8
-56,048
-2,480.11
-7,163.27
-3,994.04
-3,101.66
EBITA
-20
-21
-27
-32
-28
-22
-20
-23
-19
Gross Margin (%)
63.61
-77.78
-42.68
61.95
96
100
100
100
100
Operating Margin (%)
-6,411.08
-23,448.89
-3,768.09
-6,121.41
-56,662
-2,498.89
-7,238.55
-4,014.91
-3,117.3
Profit Margin (%)
-4,412.34
-20,802.22
-4,077.07
-6,092.35
-57,702
-2,486.67
-7,205.45
-3,552.81
-3,100.5
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-693.87
-565.72
-1,186.7
-519.48
-322.5
-162.91
-98.05
-43.68
- -
Basic EPS from Cont Ops
-368.79
-483.85
-1,186.7
-519.48
-322.5
-162.91
-98.05
-43.68
- -
Diluted Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
Diluted EPS, GAAP
-693.87
-565.72
-1,186.7
-519.48
-322.5
-162.91
-98.05
-43.68
- -
Diluted EPS from Cont Ops
-368.79
-483.85
-1,186.7
-519.48
-322.5
-162.91
-98.05
-43.68
- -

Balance Sheet (USD)

APIChatGPT
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Total Current Assets
2
5
21
4
11
9
7
3
3
+ Cash, Cash Equivalents & STI
2
4
20
3
11
9
6
2
1
+ Cash & Cash Equivalents
2
4
6
3
11
9
6
2
1
+ ST Investments
- -
- -
14
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
1
1
- -
- -
- -
1
1
+ Accounts Receivable, Net
- -
- -
1
1
- -
- -
- -
1
1
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
1
- -
1
1
1
1
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
1
1
1
1
- -
- -
- -
- -
- -
+ Property, Plant & Equip, Net
1
1
1
1
- -
- -
- -
- -
- -
+ Property, Plant & Equip
7
7
7
7
7
7
8
7
7
- Accumulated Depreciation
6
6
6
7
7
7
7
7
7
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
3
6
22
5
12
10
8
4
3
+ Payables & Accruals
4
4
7
7
5
2
2
3
5
+ Accounts Payable
2
2
2
3
3
1
2
2
4
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
2
2
4
4
2
1
1
1
1
+ ST Debt
- -
- -
- -
- -
8
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
8
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
- -
- -
- -
- -
2
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
- -
2
- -
Total Current Liabilities
4
4
7
7
13
2
3
6
5
+ LT Debt
1
3
- -
- -
1
- -
- -
- -
- -
+ LT Borrowings
1
3
- -
- -
1
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
1
- -
- -
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
1
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
2
3
- -
- -
1
- -
- -
- -
- -
Total Liabilities
6
7
7
7
14
2
3
6
5
+ Preferred Equity and Hybrid Capital
111
119
- -
- -
- -
- -
- -
- -
2
+ Share Capital & APIC
54
54
208
222
251
307
325
338
354
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
54
54
208
222
251
307
325
338
354
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-169
-187
-217
-249
-277
-300
-320
-340
-359
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-3
-14
-9
-26
-27
7
5
-2
-2
+ Minority/Non Controlling Interest
- -
12
24
24
24
- -
- -
- -
- -
Total Equity
-3
-2
15
-2
-3
7
5
-2
-2
Total Liabilities & Equity
3
6
22
5
12
10
8
4
3
Shares Outstanding
- -
- -
- -
- -
- -
- -
- -
1
3
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Debt
-1
-1
-6
-3
-1
-8
-6
-1
-1
Net Debt to Equity
18.74
77.14
-36.62
122.08
53.14
-112.52
-119.7
62.05
43.49
Tangible Common Equity Ratio
-4,037.61
-2,173.52
69.65
-49.39
-22.32
75.3
65.1
-63.65
-159.98
Current Ratio
0.48
1.19
3.2
0.58
0.86
4.17
2.95
0.57
0.5
Cash Conversion Cycle
- -
-4,531.83
-557.1
-4,535.15
-578,050.5
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
+ Net Income
-14
-19
-30
-32
-29
-22
-20
-20
-19
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
-8
-2
2
- -
1
- -
1
-2
- -
+ Stock-Based Compensation
- -
- -
- -
- -
1
1
1
- -
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
-8
-3
2
- -
- -
- -
- -
-2
- -
+ Chg in Non-Cash Work Cap
2
-1
2
- -
-1
-3
- -
- -
2
+ (Inc) Dec in Accts Receiv
- -
- -
-1
- -
1
- -
- -
-1
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
1
- -
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
1
-1
3
- -
-2
-3
- -
1
2
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-20
-21
-25
-31
-29
-25
-19
-21
-16
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-1
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
-1
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
37
14
28
33
17
12
7
+ Increase in Capital Stock
- -
- -
37
14
28
33
17
12
7
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-14
14
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
7
14
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
-21
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
-1
- -
-14
14
- -
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
6
4
-6
- -
9
-9
- -
- -
- -
+ Cash From Debt
6
10
- -
- -
9
- -
- -
- -
- -
+ Repayments of Debt
-1
-6
-6
- -
- -
-9
- -
- -
- -
+ Other Financing Activities
11
20
9
- -
-1
-1
- -
4
9
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
16
24
41
14
37
23
17
17
16
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-4
3
1
-3
8
-2
-2
-5
- -
EBITDA
-20
-21
-27
-32
-28
-22
-20
-23
-19
EBITDA Margin (%)
-6,354.75
-23,220
-3,737.29
-6,073.8
-56,048
-2,480.11
-7,163.27
-3,994.04
-3,101.66
Free Cash Flow
-21
-21
-26
-31
-29
-25
-19
-21
-16
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-13
-150
-31
-20
-34
-19
-22
-15
Free Cash Flow per Basic Share
-542.57
-553.39
-1,025.61
-502.04
-323.46
-184.38
-94.88
-46.25
- -
Price/Free Cash Flow
- -
- -
-0.76
-2.04
-1.37
-1.19
-1.43
-0.2
- -
Cash Flow to Net Income
1.41
1.14
0.86
0.96
0.99
1.13
0.96
1.06
0.87
Capital Expenditures
-1
- -
- -
- -
- -
- -
- -
- -
- -